Please ensure Javascript is enabled for purposes of website accessibility

Why Castlight Health, Caleres, and Best Buy Slumped Today

By Dan Caplinger – Nov 21, 2018 at 4:33PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Find out why these stocks missed out on a strong market day.

Wednesday gave investors some respite from the big drops that Wall Street suffered on Monday and Tuesday, as major benchmarks generally finished higher. Even though market participants seemed somewhat calmer about the state of the overall economy in quiet pre-holiday trading, many still remain nervous about the potential for a slowdown induced by rising interest rates and trade-related pressures. A few stocks responded quite negatively to company-specific issues, and Castlight Health (CSLT), Caleres (CAL -5.19%), and Best Buy (BBY -3.75%) were among the worst performers on the day. Here's why they did so poorly.

Castlight slides lower

Shares of Castlight Health fell 9.5%, continuing the wild swings that its stock has seen recently. The health benefits platform provider announced quarterly financial results earlier this month that revealed encouraging performance, including a sales increase of 16% and break-even net income on an adjusted basis. Castlight had also suggested that its full-year 2018 results would be slightly better than previously anticipated. Some pointed to news of insider sales of stock to justify the decline, but the more likely cause is just general uncertainty about Castlight's ability to make its restructuring plan pay off in the long run.

Falling stock charts superimposed over digital map of the world

Image source: Getty Images.

Caleres loses its footing

Caleres stock dropped 9% after the global footwear company reported its third-quarter financial results. The company said that its Famous Footwear retail concept saw same-store sales increase by 2.8%, posting its seventh straight year of rising comps during the key back-to-school shopping season. Yet adjusted net earnings grew less than 2%, and full-year outlooks that included just modest increases in comps for Famous Footwear didn't inspire shareholders. Given how well some rival retailers in the footwear industry did today, Caleres' numbers were disappointing.

Best Buy gives back gains

Shares of Best Buy declined 2%, giving up their gains from Tuesday following the company's release of third-quarter financial results. The electronics retailer had risen 2% after reporting a 4.3% gain in comparable-store sales and adjusted earnings that climbed almost 20% from year-earlier levels. A boost in guidance for the full 2019 fiscal year also gave investors confidence in Best Buy, but many had wondered why the company managed to avoid the broader downturn that other retailers had suffered. Today's decline seems to be making up for that disconnect, especially given that several of Best Buy's peers finished higher today.

Dan Caplinger has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Best Buy Co., Inc. Stock Quote
Best Buy Co., Inc.
$66.20 (-3.75%) $-2.58
Caleres, Inc. Stock Quote
Caleres, Inc.
$23.66 (-5.19%) $-1.29
Castlight Health, Inc. Stock Quote
Castlight Health, Inc.

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.